Bioelectronics: Revolutionizing Cancer Treatment
Transforming cancer treatment through groundbreaking electrical therapy, ONCOELECTRONICS is dedicated to improving lives with innovation and compassion.
Flexible Bioelectronics
Transforming Cancer Care
ONCOELECTRONICS is redefining cancer treatment by combining innovation, compassion, and cutting-edge technology to target tumors with precision and empower patients with new hope for extended, healthier lives.



Innovative Deeptech
Targeting
Aggressive Cancers
We have developed a disruptive technology that will change the way cancer is treated. We implant soft, flexible electrodes into tumours, and use electricity to kill and control cancer. We will extend and improve the quality of patients lives.
Precision Therapy
Target tumors with unparalleled accuracy using advanced electrical stimulation.
Innovative Design
Experience a seamless integration of soft, flexible implants for maximum comfort.
Enhanced Outcomes
Achieve improved patient survival rates with this revolutionary approach.
Revolutionizing Cancer Treatment with Precision
Discover critical data that underscores our innovation and transformative success.
Immunogenic Response
Survival Rate
Our technology has demonstrated a significant improvement in tumor immunogenicity.
Tumor
Reduction
Tumor Reduction
A measurable decrease in tumor size has been observed during preclinical trials.
Oncoelectronics’ team comprises deeptech founders with expertise in innovative medical technology, oncology, and bioengineering, all driven by a shared commitment to revolutionizing cancer treatment.

Alanna Harlton CEO
Chief Executive Officer

Rod O’Connor PhD
Chief Scientific Officer

Martin Bača PhD
Chief Technology Officer
Transforming Cancer Treatment Through Innovation
Join us in the fight against cancer and discover the power of groundbreaking technology.
Revolutionizing Cancer Care
with Precision Medicine
67 Cours Mirabeau
13100 Aix-en-Provence
FRANCE
info@oncoelectronics.com